Analyzing Common Pitfalls in Technology Transfer and Commercialization

Technology transfer sounds straightforward on paper – a technology developed in one place is handed over to another party, who then turns it into a commercial product. But in practice, the gap between a working invention and a successful product in the market is vast. Across the world, and particularly in India, a significant number of technology transfers never result in commercial success. The reasons are rarely about the technology being “bad.” More often, the failure is rooted in poor planning, mismatched partnerships, weak marketing, and logistical blindspots. Understanding these failure points is not just academic – it is essential for anyone navigating patents, licensing, or commercialization in the real world.

What does “failure of technology transfer” actually mean? 🔗

A technology transfer fails when the receiving party is unable to successfully commercialize the transferred technology – whether that means the product never reaches the market, performs poorly once it does, or generates losses that outweigh the investment. Research from experts in technology transfer consistently identifies a cluster of recurring problems: unfounded assumptions about pricing, inexperienced leadership, insufficient funding, inadequate market research, and a lack of knowledge about regulatory pathways. These are not isolated mistakes – they tend to occur in combination and reinforce each other.

In India specifically, the challenge is compounded by structural gaps. A cross-sectional study on university-industry technology transfer in India found that while researchers are increasingly aware of patents, the concept of commercialization is not deeply embedded in institutional culture. Technology Transfer Offices (TTOs) in Indian universities spend most of their energy on technology evaluation and licensing – with barely 3% of focus going to marketing. This asymmetry is itself a recipe for failure.

Raw material problems: when the supply chain doesn’t cooperate 🔗

One of the most underappreciated reasons for technology transfer failure is the non-availability or inconsistency of raw materials at the receiving location. A technology developed in a controlled R&D environment typically assumes a specific grade, quality, or type of input material. When the technology is transferred to a different site – especially in a different region or country – the same materials may not be available in the required specifications, or may be prohibitively expensive to source.

As noted in analyses of Indian technology transfer agreements, technology transfer contracts typically spell out raw material specifications, including Bills of Materials (BOM), packaging requirements, and storage instructions. When these specifications cannot be met at the receiving end, the quality of the final product suffers – sometimes catastrophically. In industries like pharmaceuticals, even minor deviations in input material can lead to batch rejections, regulatory non-compliance, and ultimately, the collapse of the commercialization effort.

The solution lies in conducting a thorough raw material feasibility assessment before finalizing any technology transfer agreement. This means verifying local supplier capabilities, conducting trial procurement, and – if necessary – building alternative supply chains before production scales up.

Site selection errors: location is not just a logistical detail 🔗

Choosing the wrong location for setting up the production facility is another leading cause of technology transfer failure. The technology transfer agreement is expected to specify requirements of plant layout, area required, location, plant and machinery, equipment selection, product environment, and infrastructure conditions. When these factors are not carefully evaluated against the chosen site, the consequences can be severe.

A site that lacks adequate power supply, water availability, skilled labor, or connectivity can derail even the most technically sound transfer. For instance, a manufacturing process requiring consistent cold-chain storage will fail at a site that faces frequent power outages. Similarly, a facility located far from the target market will face logistics costs that eat into profitability and reduce competitive advantage. In India, where infrastructure quality varies widely across regions, site selection is a critical and often underestimated decision.

Beyond logistics, site selection also has regulatory dimensions. Indian technology transfer regulations require that the receiving party holds appropriate manufacturing licenses and complies with local environmental and industry-specific norms. A site that is not appropriately zoned or licensed can stall production indefinitely, wasting the time and capital invested in the transfer.

Flawed marketing strategy: the gap between invention and demand 🔗

A technology can be scientifically brilliant and still fail commercially if the marketing strategy is wrong. Experts in technology commercialization consistently identify inadequate market research and overestimated sales projections as key drivers of failure. Companies often enter a technology transfer with optimistic assumptions about consumer demand, pricing power, and competitive landscape – none of which are validated with rigorous data.

Common marketing pitfalls 🔗

Underpricing or overpricing: Setting the wrong price point is a classic error. Underpricing erodes margins and signals low quality; overpricing reduces market penetration, especially in price-sensitive markets like India. Both stem from insufficient market research.

Ignoring the competition: A unique scientific approach does not automatically translate into uniqueness in the marketplace. Technologies often enter markets where alternative solutions already exist – sometimes cheaper and more familiar to consumers. Failing to map the competitive landscape before commercialization leads to products that struggle to gain a foothold.

No coherent distribution strategy: Knowing who your customer is matters little if you cannot reach them. A technology transferred from a foreign firm may find that the distribution networks that work in the home country simply do not exist in India, requiring the licensee to build these channels from scratch – a costly and time-consuming process that can cripple the business before it generates revenue.

The fix is straightforward in theory but demanding in practice: conduct thorough market research before the technology transfer agreement is finalized, not after. Comprehensive market assessments, a clear understanding of the target customer base, and a tailored value proposition are among the most reliable predictors of commercialization success.

Partnership problems: when the licensor-licensee relationship breaks down 🔗

Technology transfer is fundamentally a relationship between two parties – the technology provider and the recipient. When that relationship is dysfunctional, the transfer is almost certain to fail. Failed transfers are as common as successful ones precisely because each side is often inadequately informed about the other’s motivations and expectations.

Misaligned expectations 🔗

The licensor may believe the technology is ready for immediate commercialization, while the licensee may require significant further development before production can begin. Research has shown that the more additional development a firm needs to implement on a transferred technology, the more likely the commercialization is to fail. This gap in understanding about the technology’s readiness creates friction from the very start.

The consultant problem 🔗

Many technology transfers involve intermediaries – consultants who facilitate the deal between the technology provider and the recipient. An unsuitable consultant who does not deeply understand either the technology or the target market can misrepresent capabilities, create unrealistic timelines, or fail to identify fundamental incompatibilities between the parties. An unsuitable consultant and inadequate valuation of the technology are two of the most frequently cited structural causes of transfer failure.

Breakdown in cooperation 🔗

Even after a deal is signed, ongoing cooperation between the technology provider and the recipient is critical. When the licensor disengages after the initial transfer – providing no technical support, training, or troubleshooting assistance – the licensee is left to figure out a complex process on their own. Studies confirm that the degree of cooperation with the technology provider has a strong positive correlation with commercialization success. In India, where the technology recipient may be bridging a significant knowledge gap, this post-transfer support is not optional – it is essential.

Weak IP protection and inadequate technology valuation 🔗

A recurring cause of failure that is specific to patent-linked technology transfers is poor intellectual property protection. When patent protection is weak – often because attorneys are not given a deep enough understanding of the technology’s attributes – the patent may not survive a legal challenge, leaving the licensee without the exclusivity they paid for.

In India, Section 83(c) of the Patents Act, 1970 recognizes that patent protection contributes directly to the promotion of technological innovation and to the transfer and dissemination of technology. However, a patent that is granted but not robustly protected is of limited commercial value. If competitors can design around the patent or if the patent is invalidated due to drafting errors, the commercial foundation of the entire transfer collapses.

Related to this is the issue of technology valuation. When the value of the technology has not been adequately determined before the transfer, either party may end up on the wrong end of the deal – the licensor underselling a valuable technology, or the licensee overpaying for something that cannot be profitably commercialized. Fair and accurate valuation, ideally conducted by an independent expert, is a non-negotiable step before any transfer agreement is executed.

Financial and systemic barriers 🔗

Insufficient funding is another major factor. Many technology transfers stall not because of technical or market failures, but simply because the licensee runs out of capital before reaching commercial viability. Market uncertainty, technological issues, and a lack of funding capability are repeatedly cited as causes of failure in technology commercialization.

Beyond direct funding, systemic barriers – bureaucratic processes, complex regulatory clearances, and intellectual property rights disputes – add layers of delay and cost. For Indian universities and research institutions, regulatory factors and the effectiveness of Technology Transfer Offices are among the most significant determinants of whether a commercialization effort succeeds or fails. When these systemic supports are weak, even a well-funded and technically sound transfer can get mired in procedural delays.

Strategies to reduce the risk of failure 🔗

While no checklist can guarantee success, the following practices significantly reduce the risk of technology transfer failure:

Pre-transfer due diligence: Thoroughly assess raw material availability, site infrastructure, regulatory requirements, and market conditions before signing any agreement.

Realistic financial planning: Build in contingency funding and do not assume that revenue will arrive on the earliest projected date. Technology commercialization almost always takes longer and costs more than initial estimates.

Right team and right partners: Assemble a team with complementary expertise – technical, marketing, legal, and financial. Choose a technology provider who will remain engaged post-transfer, not one who disappears after the ink dries.

Robust IP protection: Ensure that patents covering the technology are properly drafted and enforceable. Conduct a freedom-to-operate analysis to check for potential infringement by competitors.

Ongoing market research: Markets change. A commercialization strategy based on research done two years before launch may be outdated by the time the product reaches consumers. Build mechanisms for continuous market feedback into the commercialization plan.

In the Indian context, structured models for patent commercialization – such as the IBRMI framework developed for centrally funded technical institutions – offer a systematic approach to addressing the gaps that cause most Indian technology transfers to underperform relative to their global counterparts.

What do you think? Given how often technology transfers fail due to poor market research and misaligned partnerships, should Indian universities be required to demonstrate commercial viability before a patent is licensed to an industry partner? And when a technology transfer fails mid-way, who should bear the financial burden – the licensor, the licensee, or both equally?

References

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC11144850/
2. https://link.springer.com/article/10.1007/s13132-021-00747-4
3. https://www.mondaq.com/india/new-technology/1299444/technology-transfer-a-necessity-for-the-growth-of-the-world-economy
4. https://ksandk.com/information-technology/technology-transfer-regulations-in-india/
5. https://www.linkedin.com/pulse/why-technology-transfer-commercialization-processes-fail-rojas-leal
6. https://techtransfercentral.com/2011/05/25/7-reasons-why-academic-scientists-fail-at-commercialization/
7. https://pezhvac.weebly.com/technology-transfer-failure.html
8. https://www.researchgate.net/publication/318705027_What_Causes_Technology_Commercialization_to_Succeed_or_Fail_after_Transfer_from_Public_Research_Organizations
9. https://www.lexology.com/library/detail.aspx?g=784564cc-282d-4825-a4fa-533de46b5c5f
10. https://www.scirp.org/journal/paperinformation?paperid=134627